Eric W. Roberts - 05 Jun 2025 Form 4 Insider Report for CalciMedica, Inc. (CALC)

Signature
/s/ John Dunn, Esq., Attorney-in-Fact
Issuer symbol
CALC
Transactions as of
05 Jun 2025
Net transactions value
+$17,545
Form type
4
Filing time
09 Jun 2025, 16:08:15 UTC
Previous filing
25 Apr 2025
Next filing
13 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Roberts Eric W CHIEF BUSINESS OFFICER, Director, 10%+ Owner C/O CALCIMEDICA, INC., 505 COAST BLVD. S. #307, LA JOLLA /s/ John Dunn, Esq., Attorney-in-Fact 09 Jun 2025 0001576244

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CALC Common Stock Purchase $8,670 +5,100 +39% $1.70 18,323 05 Jun 2025 By FMTC Custodian - Roth IRA FBO Eric W. Roberts F1
transaction CALC Common Stock Purchase $8,875 +5,000 +27% $1.78 23,323 06 Jun 2025 By FMTC Custodian - Roth IRA FBO Eric W. Roberts F2
holding CALC Common Stock 164,706 05 Jun 2025 Direct
holding CALC Common Stock 49,894 05 Jun 2025 By Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA
holding CALC Common Stock 10,661 05 Jun 2025 By IRA Financial Trust Company CFBO Eric W. Roberts
holding CALC Common Stock 356,989 05 Jun 2025 By Valence Investments SPV IV, LLC
holding CALC Common Stock 66,228 05 Jun 2025 By Valence Investments SPV V, LLC
holding CALC Common Stock 316,109 05 Jun 2025 By Valence Investments SPV VI, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction reported was $1.70, and the range of prices were between $1.6638 an $1.7274. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F2 The weighted average purchase price for the transaction reported was $1.755, and the range of prices were between $1.75 and $1.87. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.